Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1356553408
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
619 19th St S
Birmingham, AL, 35249
Phone (205) 934-4011
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
109,547 services
Medicare patients, 2024
351
Average age 74
Drug cost, 2024
$3.8M
2,722 prescriptions
Company payments, 2025
$45.22
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Racquel D Innis-Shelton was code J1459 (injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg), 4,230 times for 15 patients. In total Racquel D Innis-Shelton billed 109,547 services in 107 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,230 | 15 | $36.47 | $154K |
| J0897 Injection, denosumab, 1 mg | Office | 3,540 | 25 | $20.24 | $72K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,860 | 27 | $0.09 | $167 |
| 85025 Blood Count | Office | 1,047 | 307 | $7.51 | $7,865 |
| 36415 Venipuncture Blood Collection | Office | 1,001 | 305 | $8.53 | $8,535 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 950 | 20 | $0.76 | $719 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 932 | 11 | $0.07 | $69.4 |
| J1750 Injection, iron dextran, 50 mg | Office | 880 | 39 | $13.67 | $12K |
| 96367 Intravenous Infusion, Hydration | Office | 564 | 82 | $19.05 | $11K |
| 99214 Office E&M - Established | Office | 464 | 204 | $86.75 | $40K |
| Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 456 | 11 | $262.56 | $120K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 314 | 192 | $11.70 | $3,672 |
| 96361 Intravenous Infusion, Hydration | Office | 276 | 39 | $8.07 | $2,226 |
| 96413 Chemotherapy Administration | Office | 242 | 42 | $86.60 | $21K |
| 96372 Injection Administration | Office | 215 | 56 | $9.71 | $2,089 |
By year: 2022 $1.5M for 114,940 services; 2023 $1.5M for 120,888 services; 2024 $1.6M for 109,547 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,047 | 307 | $7.51 | $7,865 |
| 36415 Venipuncture Blood Collection | 1,001 | 305 | $8.53 | $8,535 |
Medicare prescription drug claims, 2024
In 2024, the drug Racquel D Innis-Shelton prescribed most often to Medicare patients was Letrozole, with 148 prescriptions and refills. In total Racquel D Innis-Shelton wrote 2,722 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 148 | 356 | 47 | $4,159 |
| Eliquis Apixaban | 120 | 170 | 28 | $98K |
| Ondansetron Hcl Generic | 100 | 101 | 52 | $1,493 |
| Oxycodone Hcl Generic | 90 | 90 | 15 | $812 |
| Valacyclovir Valacyclovir Hcl | 77 | 113 | 27 | $4,775 |
| Prochlorperazine Maleate Generic | 75 | 78 | 46 | $1,119 |
| Exemestane Generic | 72 | 158 | 21 | $22K |
| Levothyroxine Sodium Generic | 71 | 105 | 20 | $625 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 27 | $1,212 |
| Hydroxyurea Generic | 67 | 108 | 13 | $2,545 |
| Gabapentin Generic | 63 | 79 | 16 | $871 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 56 | 86 | 20 | $955 |
| Potassium Chloride Generic | 54 | 63 | 18 | $1,000 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 53 | 53 | 18 | $1,181 |
| Pregabalin Generic | 51 | 51 | 13 | $849 |
Brand drugs: - claims; generic drugs: 2,262 claims; opioid claims: 332.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Racquel D Innis-Shelton $45.22 ($45.22 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $25.61.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.